Introduction
neovascularization inside the chamber is critical for preventing hypoxia and hence facilitating growth of the constructed tissue graft in the chamber.
Angiogenesis is a complex, tightly regulated process that occurs through degradation of extracellular matrix, and the migration, proliferation and morphogenesis of endothelial cells, involving many growth factors, cytokines and multiple signalling pathways [10] . Vascular [11] [12] [13] . Indeed, endogenously generated ROS are known to serve as second messengers, activating multiple intracellular signalling pathways that have key roles in vascular cell biology [13] . This notion is underlined by the observations that angiotensin II, a major stimulus for vascular ROS production, also plays an important role in angiogenesis [11, 12] .
endothelial growth factor (VEGF) is one of the most important angiogenic growth factors involved in the angiogenic response both in vitro and in vivo. Recently it has been found that VEGF stimulates generation of reactive oxygen species (ROS) in endothelial cells, and ROS are involved in mediating the angiogenic activities of endothelial cells
The reduced ␤-nicotinamide adenine dinucleotide phosphate (NADPH) oxidase has been identified in vascular tissues as a major source of ROS [14, 15] . Tojo et al. recently [16] , indicating that the Nox2 NADPH oxidase is a critical component in the signalling networks driving hypoxia-induced angiogenesis.
provided evidence that NADPH oxidase is directly involved in angiogenesis induced by ischemia in vivo. Using a hind limb ischaemia model, they showed that there was an increase in expression of the catalytic subunit Nox2 and generation of superoxide in the angiogenic area, and both the infiltrating inflammatory cells and resident vascular cells contributed to this process. Moreover, the angiogenic response was significantly impaired either by in vivo treatment with the antioxidant ebselen, or in Nox2-deficient mice
We have systemically characterized the angiogenic processes in the chamber [8] , but little is known about the underlying cellular and molecular mechanisms. Based on the evidence of the involvement of NADPH oxidase in ischaemic angiogenesis, we set out to investigate whether NADPH oxidase is involved in the angiogenic process in the TE chamber. Figure 2 . From day 10 to 14, the overall vessel density remained similar to that of day 7 (Fig. 1) . Histological examination revealed that, as compared to day 7, many vessels at these later stages had a more distinct, thicker vessel wall, which has recruited multi-layered mural cells (Fig. 1) (Fig. 4) . A number of mononuclear cells scattered in the tissue were Nox2 positive, whereas these cells were probably ED-1 positive also (Fig. 4) . In the day-10 specimen, Nox2 was detected in both endothelial cells and mural cells in the multi-layered wall of new vessels (Fig. 4) wall of the new vessels (Figure 4) . This phenomenon could not be observed at 10 days.
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Results
Angiogenic response in the chamber
We also attempted to localize Nox4 expression using the 7-day specimen, but the Nox4 antibody could not detect the antigen in paraffin sections. When Nox4 immunohistochemistry was performed in frozen sections, the specificity of the immunoreactivity was confirmed by negative control sections in which the primary antibody was replaced by equal concentration of non-specific IgG from the same species (Fig. 4G insert) . In contrast to the highly localized expression of Nox2, Nox4 was expressed in most cells including the endothelium, mural cells and fibroblast-like spindle cells (Fig. 4) . In comparison to the Nox2 staining, the endothelial cells did not express more Nox4 than other cell types. (Fig. 5) (Fig. 5) . Some of the fluorescent cells formed structures that resembled new blood vessels (Fig. 5) . However, given the poor resolution of tissue structure in the DHE fluorescent slides, it is difficult to precisely match the pattern of cellular superoxide with the NADPH oxidase expression. Figure 6B , the cell number was slightly reduced (PϽ0.05) by apocynin at 24 
Localization of superoxide production
Apocynin inhibited NADPH oxidase activity and angiogenesis in vitro
In order to determine the role of NADPH oxidase in angiogenesis in vitro, we used the NADPH oxidase inhibitor apocynin in cultured HMECs. Treatment of HMECs with apocynin (2 and 10 mM for 1 hr) concentration-dependently reduced the NADPH oxidase activity (Fig. 6A). Next, we examined whether long-term inhibition of NADPH oxidase by apocynin affects the survival of endothelial cells. As shown in
hrs, while at 72 hrs, the reduction in cell number was more obvious. This observation is consistent with our previous finding that inhibition of NADPH oxidase expression in HMECs induced an apoptotic response (caspase 3/7 activation). Then we assessed in vitro angiogenic responses in HMECs using tube formation and wound healing assays. Apocynin at both concentrations significantly inhibited the tube formation and wound healing responses (Figs 6C and D). In the following in vivo studies, we used 10 mM of apocynin for local treatment.
Apocynin suppressed vessel growth in the chamber
To determine the role of NADPH oxidase in neovascularization of the AVL chamber, we tested the effects of apocynin locally applied in the chamber. As shown in Figure 7A , (Fig. 7A) . (Fig. 7C) . [12] . In this study, we provide evidence that NADPH oxidase is intimately involved in the angiogenic process in vivo inside our tissue-engineering chambers. A major difference between our study and previous ones is that the angiogenic process in the chamber occurred in the absence of any obvious physiological or pathophysiological triggers of angiogenesis, such as tissue ischaemia or release of growth factors [11, 16, 19] 
treatment with apocynin remarkably retarded the vessel growth into the Matrigel surrounding the AV loop. The vessel density between the artery and vein stems was reduced by about 50% in the apocynin-treated chambers at 14 days (Fig. 7B). We also found that the apocynincontaining Matrigel did not prevent the infiltration of inflammatory cells prior to vessel development in unorganized areas
To further confirm the effects of NADPH oxidase inhibition on
Fig. 3 Time course of the expression levels of mRNA of the NADPH oxidase Nox4 and Nox2 in the chamber tissue. Data (mean ϮS.E.M.) are expressed as fold of the mean level of day 3. *PϽ0.05 versus day 3, one-way analysis of the variance (ANOVA) followed by Newman-Keuls t-test, n ϭ 6-7. neovascularization, we tested the effects of a specific peptidyl inhibitor gp91ds-tat (100 µM). Treatment with gp91ds-tat for 14 days reduced the vessel density by 84.8% as compared to those treated with the scrambled control peptide
Discussion
Vascular NADPH oxidase and the ROS molecules produced by this enzyme have emerged as key regulators of angiogenesis
. Rather, the new vessel growth sprouted spontaneously from a patent arterial-venous loop, occurring in a milieu of granulation tissue formation. This process was preceded by early fibrin deposition and subsequent inflammatory cell infiltration, which resembles the wound healing process in the
(A, C, E) Nox2 expression (red) in new blood vessels (arrow heads) and infiltrating leukocytes (arrows) in the chamber tissue at 3, 7 and 10 days. (B, D, F) Expression of ED-1 (brown) in infiltrating leukocytes (arrow heads) in the chamber tissue at 3, 7 and 10 days. (G) Expression of Nox4 (red colour) in the chamber tissue at 7 days. The insert shows a negative control section, in which non-specific IgG was used instead of the primary antibody. (H) We have observed that at day 7, some ED-1+ cells appeared to be incorporated in the new vessel (arrow heads). Such ED-1+ cells could not be observed in the vessels at day 10. Endothelial cells of the new vessel were ED-1 negative. * indicates the lumen of new blood vessels. n ϭ 4 at each time point.
skin. Interestingly, our finding is supported by a recent report that low concentrations of H2O2 accelerated, whereas catalase slowed, the angiogenesis and healing process of dermal wounds in vivo [20] . [21] . Recently, we demonstrated that blockade of Nox4 expression or function inhibited angiogenic responses in cultured endothelial cells [22] . On the other hand, the importance of Nox2 in angiogenesis has been documented under both in vitro and in vivo conditions [11, 16] . A limitation of the present study is that we could not distinguish the specific roles of Nox2 and Nox4 in neovascularization in the chamber. Given that both Nox2 and Nox4 are expressed and are involved in redox modulation in endothelial cells [11, 23] , we speculate that both isoforms may be involved in promoting neovascularization in the chamber. [24, 25] . There is evidence that NADPH oxidase and ROS molecules are involved in regulating proliferation and phenotypic switch of mural cells [25] [26] [27] . Moreover, Nox4 expressed in mesenchymal cells may stimulate angiogenesis via paracrine effects by releasing cell permeable H2O2 [28] , which has potent pro-angiogenic actions [12] . It seems, however, paradoxical that Nox2 expression decreased at day 7 as compared to day 3, while there was a dramatic concomitant [29] . At this stage, non-leukocytes [19, 30, 31] (Fig. 6A) , similar to that occurring in the fibrin clot in chambers without Matrigel (Fig. 1) the data in Figure 2 and Figure 7B, 
Taken together, we suggest that NADPH oxidase and subsequent redox signalling have important roles in promoting tissue regeneration by acting as key intermediates in angiogenesis. The expression of Nox4 increased with the formation and maturation of new vessels during tissue growth in the TE chamber. A role of Nox4 in promoting angiogenesis is emerging. It was found that focal brain ischaemia resulted in prominent expression of Nox4 in the new capillaries, indicating an involvement of Nox4 in hypoxia-induced angiogenesis
Immunohistochemistry experiments revealed that Nox4 is expressed in mesenchymal cells as well as in endothelial cells, indicating that Nox4 may be also involved in vessel maturation. This is supported by the observation that Nox4 expression continued to increase even after the vessel density has reached the plateau. In mature arteries, Nox4 is expressed in both vascular smooth muscle cells and fibroblasts
Fig. 6 Effects of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor apocynin on (A) NADPH oxidase activity, (B) cell viability and (C, D) angiogenic responses in cultured Human microvascular endothelial cells (HMEC) cells. (A) Cells
